Choose your language

Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014

Rodman & Renshaw Conferences, LLC, today
announced that – former United States Secretary of State and retired
four star general – Colin L. Powell will present the keynote address for
the 2014 Rodman & Renshaw Annual Global Investment Conference, sponsored
by H.C. Wainwright & Co., LLC, at The Palace Hotel in New York. General
Colin L. Powell’s address is scheduled for Tuesday, September 9, 2014 at
8:00am in the Villard Ballroom. The Conference will be held September 9
and 10, 2014 with more than 250 public & private companies from around
the world expected to present to an audience of over 2,000 attendees.
The two day event will feature tracks devoted to
Biotechnology/Healthcare, Metals & Mining, Technology, Cleantech and
Growth. The Conference will include corporate presentations and Q&A
sessions, investor one-on-one meetings and daily networking
opportunities. Institutional investors, venture capitalists, private
equity firms, sophisticated private investors and industry executives
are welcome to attend this conference. Register online at the Rodman &
Renshaw Conference website at or
contact Lily Khaykina, Rodman & Renshaw’s Conference Manager, at (212)
356-0529 or via e-mail at



Presenting Companies


Healthcare/Life Sciences

Metals & Mining

Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) Adriana Resources Inc. (TSX: ADI.V)
Active Biotech AB (NASDAQ OMX Stockholm: ACTI) Alexco Resource Corp. (NYSE-MKT: AXU)
Advaxis, Inc. (NASDAQ: ADXS) AuRico Gold Inc. (NYSE: AUQ)
Aeterna Zentaris Inc. (Nasdaq: AEZS) Avalon Rare Metals Inc. (NYSE; TSX: AVL)
Agenus Inc. (NASDAQ: AGEN) Avino Silver & Gold Mines Ltd. (TSX-V, NYSE: ASM)
Akers Biosciences, Inc. (AKER: NASDAQ) Azarga Uranium Corp. (TSX: AZZ)
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) Balmoral Resources Ltd. (TSX: BAR)
Alliqua, Inc. (NASDAQ: ALQA) Caledonia Mining Corporation (Toronto: CAL.TO)
Amarantus BioScience Holdings, Inc. (OTC BB: AMBS) Coeur Mining, Inc. (NYSE: CDE)
Amarin Corporation plc (NASDAQ: AMRN) Comstock Mining Inc. (NYSE MKT: LODE)
AmpliPhi Biosciences Corporation (OTC BB: APHB) Endeavour Silver Corp. (NYSE: EXK)
Anavex Life Sciences Corp. (OTC BB: AVXL)

Energold Drilling Corp. (Toronto Venture Stock

AntriaBio, Inc. (OTC BB: ANTB)
Applied DNA Sciences, Inc. (OTC BB: APDN) Energy Fuels Inc. (NYSE MKT: UUUU)
Apricus Biosciences, Inc. (NASDAQ: APRI) Excalibur Resources Ltd. (OTCQX: EXCFF)
ARCA biopharma, Inc. (Nasdaq: ABIO) Fission Uranium Corp. (TSX.V: FCU.V)
Arch Therapeutics, Inc. (OTC: ARTH) Focus Graphite Inc. (TSX.V: FMS)
Argos Therapeutics, Inc. (ARGS: NASDAQ) General Moly, Inc. (NYSE MKT and TSX: GMO)
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) Golden Minerals Company (NYSE MKT: AUMN)
Arno Therapeutics, Inc. (OTCQB: ARNI) Golden Queen Mining Co. Ltd. (TSX / OTCQX: GQM)
Atossa Genetics, Inc. (NASDAQ: ATOS) Golden Star Resources Ltd. (NYSE MKT: GSS)
Biocept, Inc. (NASDAQ: BIOC)

Great Panther Silver Limited (TSX and

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX)
BioLife Solutions, Inc. (NASDAQ: BLFS) Hecla Mining Company (NYSE: HL)

BioLight – Israeli Life Sciences Investments Ltd.

MAG Silver Corp. (NYSE MKT: MVG)
Mines Management, Inc. (NYSE MKT: MGN)
BioLineRx Ltd. (NASDAQ: BLRX) NovaGold Resources Inc. (TSX, NYSE-MKT: NG)
Bionomics Limited (ASX: BNO.AX) Paramount Gold and Silver Corp. (NYSE MKT: PZG)
BioSpecifics Technologies Corp. (NASDAQ: BSTC) Pershing Gold Corporation (OTC BB: PGLC)
BioTime, Inc. (NYSE: BTX) PolyMet Mining Corp. (NYSE MKT: PLM)
Boston Therapeutics, Inc. (OTCQB: BTHE) Rare Element Resources Ltd. (NYSE MKT: REE)
Brabant Pharma Revett Mining Company, Inc. (NYSE MKT / TSX: RVM)
Brainstorm Cell Therapeutics Inc. (OTC BB: BCLI) Solitario Exploration & Royalty Corp. (NYSE MKT: XPL)
BSD Medical Corporation (NASDAQ: BSDM) Stria Capital Inc. (TSX.V: SRA)
Cambrex Corporation (CBM: NYSE) Ur-Energy Inc. (NYSE MKT: URG)
Can-Fite BioPharma, Ltd. (NYSE MKT: CANF) Uranerz Energy Corporation (NYSE MKT: URZ)
Capstone Therapeutics Corp. (OTCQB: CAPS) Uranium Energy Corp. (NYSE MKT: UEC) (
Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) Uranium Resources, Inc. (NASDAQ: URRE)
Ceapro Inc. (TSX: CZO.V) Victory Nickel Inc. (TSX: NI.TO)
Celator Pharmaceuticals, Inc. (NASDAQ: CPXX) Vista Gold Corp. (NYSE MKT & TSX: VGZ)
Cell Source Ltd. (OTC BB: CLCS) Wellgreen Platinum Ltd. (TSX: WG.V)
Cellceutix Corporation (OTC: CTIX)
Cellectar Biosciences, Inc. (OTCQX: CLRB)


Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) 5BARz International, Inc. (OTCQB: BARZ)
Celsion Corporation (NASDAQ: CLSN) Arotech Corporation (NASDAQ: ARTX)
Cesca Therapeutics Inc. (NASDAQ: KOOL) Camtek Ltd. (NASDAQ: CAMT)
Champions Oncology, Inc. (OTC BB: CSBR) China XD Plastics Company Limited (NASDAQ: CXDC)
Chembio Diagnostics, Inc. (NASDAQ: CEMI) Cimatron Ltd. (NASDAQ CM: CIMT)
Cleveland BioLabs, Inc. (Nasdaq: CBLI) Crowdgather, Inc. (OTCQB: CRWG)
CoDa Therapeutics, Inc. Data I/O Corporation (NASDAQ: DAIO)
Columbia Laboratories, Inc. (Nasdaq: CBRX) Dot Hill Systems Corp. (NASDAQ: HILL)
ContraVir Pharmaceuticals, Inc. (OTC BB: CTRV) DragonWave Inc. (NASDAQ: DRWI)
Corbus Pharmaceuticals, Inc. Elbit Vision Systems Ltd. (OTC BB: EVSNF)
Cortex Pharmaceuticals, Inc. (Other OTC: CORX) Implant Sciences Corporation (OTC: IMSC)
Critical Outcome Technologies Inc. (TSX: COT.V) Information Services Group, Inc. (NASDAQ: III)
Curis, Inc. (NASDAQ: CRIS) Inventergy Inc. (NASDAQ: INVT)
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) Local Corporation (NASDAQ: LOCM)
Cynapsus Therapeutics Inc. (TSX.V: CTH.V)

Magic Software Enterprises Ltd. (NASDAQ Global Select

Cytomedix, Inc. (OTC BB: CMXI)
CytoSorbents Corporation (OTCBB: CTSO) NetDimensions (Holdings) Limited (OTCQX: NETDY)
CytRx Corporation (NASDAQ: CYTR) Novatel Wireless, Inc. (NASDAQ: NVTL)
DARA BioSciences, Inc. (NASDAQ: DARA) PCM, Inc. (NASDAQ: PCMI)
DelMar Pharmaceuticals, Inc. (OTC BB: DMPI) Pharma-Bio Serv, Inc. (OTCBB: PBSV)
Dendreon Corporation (NASDAQ: DNDN) Pointer Telocation Ltd. (NASDAQ: PNTR)
DiaMedica Inc. (TSX-V: DMA.V) RealNetworks, Inc. (NASDAQ: RNWK)
Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) Rightscorp, Inc. (OTCQB: RIHT)
DURECT Corporation (NASDAQ: DRRX) Sebring Software, Inc. (OTC: SMXI)
EDAP TMS S.A. (NASDAQ: EDAP) Single Touch Systems, Inc. (OTC BB: SITO)
Elite Pharmaceuticals, Inc. (OTC BB: ELTP) Smith Micro Software, Inc. (NASDAQ: SMSI)
Elk OrthoBiologics Limited Soul and Vibe Interactive Inc. (OTCQB: SOUL)
Emisphere Technologies, Inc. (OTC BB: EMIS) SuperCom Ltd. (NASDAQ: SPCB)
Epizyme, Inc. (NASDAQ: EPZM) Surna Inc. (OTCQB: SRNA)
Fate Therapeutics, Inc. (NASDAQ: FATE) USA Technologies, Inc. (NASDAQ: USAT)
Galena Biopharma, Inc. (Nasdaq: GALE) UTStarcom Holdings Corp. (NASDAQ: UTSI)
GenSpera, Inc. (OTCQB: GNSZ) Viggle Inc. (NASDAQ: VGGL)
GenVec, Inc. (NASDAQ: GNVC) Viscount Systems Inc. (OTCQB: VSYS)
GeoVax Labs, Inc. (OTCQB: GOVX) Vuzix Corporation (OTCQB: VUZI)
Guided Therapeutics, Inc. (OTCQB: GTHP)
Heat Biologics, Inc. (Nasdaq: HTBX)


HedgePath Pharmaceuticals, Inc. (OTCQB: HPPI) Axion International Holdings, Inc. (OTCQB: AXIH)
Hemispherx Biopharma, Inc. (NYSE MKT: HEB) BioLargo, Inc. (OTCBB: BLGO)
Immune Pharmaceuticals, Inc. (OTC BB: IMNP) China Recycling Energy Corporation (NASDAQ: CREG)
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) Deinove S.A. (Paris: ALDEI.PA)
Insmed Incorporated (NASDAQ: INSM) Gulf Resources, Inc. (NASDAQ: GURE)
IntelGenx Technologies Corp. (Toronto and NYSE: IGXT) Magnolia Solar Corporation (OTC BB: MGLT)
International Stem Cell Corporation (OTC BB: ISCO) U.S. Geothermal, Inc. (NYSE MKT: HTM)
InVivo Therapeutics Holdings Corp. (OTCQB: NVIV) UQM Technologies, Inc. (NYSE: UQM)
Kamada Ltd. (Nasdaq: KMDA)
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX)


La Jolla Pharmaceutical Company (NASDAQ: LJPC) Asia Pacific Wire & Cable Corporation Limited (NASDAQ:
LabStyle Innovations Corp. (OTC BB: DRIO) APWC)
Lion Biotechnologies, Inc. (LBIO: OTC BB) Calpian, Inc. (OTC BB: CLPI)
Lixte Biotechnology Holdings, Inc. (OTC BB: LIXT) China Green Agriculture, Inc. (NYSE: CGA)
MabVax Therapeutics Inc. (OTCQB: TELK) Highpower International, Inc. (NASDAQ: HPJ)
Marina Biotech, Inc. (OTC BB: MRNA) HPEV, Inc. (OTCBB: WARM)
Mast Therapeutics, Inc. (NYSE MKT: MSTX) Lifetime Brands, Inc. (NASDAQ: LCUT)
Matinas BioPharma, Inc. (OTCBB: MTNB) Manitex International, Inc. (NASDAQ: MNTX)
MaxCyte, Inc. Orient Paper, Inc. (NYSE: ONP)
Mayne Pharma Group Limited (ASX: MYX.AX) Reed’s, Inc. (NYSE MKT: REED)
MDxHealth, Inc. (EURONEXT: MDXH) Sysorex Global Holdings Corp. (NASDAQ: SYRX)
MELA Sciences, Inc. (NASDAQ: MELA) Top Image Systems Ltd. (NASDAQ: TISA)
Metastat, Inc. (OTCQB: MTST) Xueda Education Group (NYSE: XUE)
MYOS Corporation (OTC BB: MYOS)
NanoViricides, Inc. (NYSE.MKT: NNVC)
NeoStem, Inc. (Nasdaq: NBS)
NephroGenex, Inc. (NASDAQ: NRX)
Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT)
Neuralstem, Inc. (NYSE Amex: CUR)
NeuroMetrix, Inc. (NASDAQ: NURO)
Northwest Biotherapeutics, Inc. (NASDAQ: NWBO)
NovaBay Pharmaceuticals, Inc. (NYSEMKT: NBY)
Novan Therapeutics
Novogen Limited (NASDAQ: NVGN)
Nuvo Research Inc. (TSX: NRI.TO)
Ocera Therapeutics, Inc. (NASDAQ: OCRX)
OncoSec Medical Incorporated (OTC BB: ONCS)
Oncothyreon Inc. (Nasdaq: ONTY)
Opexa Therapeutics, Inc. (Nasdaq: OPXA)
Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP)
OSE Pharma SA
OvaScience, Inc. (NASDAQ: OVAS)
PharmAthene, Inc. (NYSE MKT: PIP)
Pluristem Therapeutics Inc. (NASDAQ: PSTI)
PositiveID Corporation (OTC Markets: PSID)
Pressure BioSciences, Inc. (OTCQB: PBIO)
Prosensa Holding N.V. (NASDAQ: RNA)
Protalex, Inc. (OTC BB: PRTX)
Protalix BioTherapeutics, Inc. (NYSE MKT: PLX)
Provista Diagnostics, Inc.
PURE Bioscience, Inc. (OTC BB: PURE)
RedHill Biopharma Ltd. (NASDAQ: RDHL)
RepliCel Life Sciences Inc. (TSXV: RP)
RestorGenex Corporation (OTC BB: RESX)
Resverlogix Corp. (TSX: RVX.TO)
Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN)
Rosetta Genomics Inc. (NASDAQ: ROSG)
Ruthigen, Inc. (NASDAQ: RTGN)
RXi Pharmaceuticals Corporation (NASDAQ: RXII)
Soligenix, Inc. (OTC BB: SNGX)
Sorrento Therapeutics, Inc. (NASDAQ: SRNE)
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)
SQI Diagnostics Inc. (TSX.V: SQD.V)
Stellar Biotechnologies, Inc. (OTC QB: SBOTF)
StemCells, Inc. (NASDAQ: STEM)
Stemline Therapeutics, Inc. (Nasdaq: STML)
Stevia First Corp. (OTC BB: STVF)
Synthetic Biologics, Inc. (NYSE MKT: SYN)
Taxus Cardium Pharmaceuticals Group Inc. (OTC: CRXM)
TG Therapeutics, Inc. (NASDAQ: TGTX)
Threshold Pharmaceuticals, Inc. (NASDAQ: THLD)
Titan Pharmaceuticals, Inc. (OTC BB: TTNP)
Tolero Pharmaceuticals, Inc.
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP
Transgenomic, Inc. (NASDAQ: TBIO)
Transition Therapeutics Inc. (Nasdaq: TTHI)
Trillium Therapeutics Inc. (OTCQX: SCTPF)
United Therapeutics Corporation (NASDAQ: UTHR)
Venaxis, Inc. (NASDAQ: APPY)
Vical Incorporated (NASDAQ: VICAL)
WaferGen Bio-systems, Inc. (OTC: WGBS)


Marquee Sponsor


Gold Sponsors

Corporate Stock Transfer, Inc., Marcum LLP, William O’Neil + Company

Silver Sponsors

Bloomberg Brief, Castle Brands (NYSE MKT: ROX), Chord Advisors,, IRTH Communications, MarketNexus Media, SEC Compliance,
Sichenzia Ross Friedman Ference LLP, StockVest Quarterly, theIRapp®, Uber